Chan S, Slawsky K, Prottas C, Feldmann J, & Goss T (March 2010). Recognizing Value in Oncology Innovation. White Paper.
Weber PA, Wirostko BM, Xu X, Goss TF, Zlateva G. Newly Diagnosed Exudative Age-Related Macular Degeneration Treated With Pegaptanib Sodium Monotherapy in US Community-Based Practices: Medical Chart Review Study. BMC Ophthalmology 2010. 10(2), In Press.
Chan S quoted in Fontanazza M (2009, Spring). Q&A: Where Evidence Is King. Med-Tech Precision. 2(1), 18-19.
Mathews C, Geldart T, & McInnis M (2009, August 31). Improving Healthcare Through Diagnostics: The Future of IVDs. Clinica Diagnostics. 50, 1-5.
Mathews C (2009, July 6). Cost-Savings or Value Capture: IVD Industry at a Crossroads. Clinica Diagnostics. 46, 1-5.
Mathews C quoted in Perriello B (2009, October 1). MassDevice Q&A: Charles Mathews. Massachusetts Medical Devices Journal LLC. Published on MassDevice at www.massdevice.com.
Morton J, Patel ST, Anastassopoulos KP, Lerner JH, Ryan KJ, Goss TF, & Dodd SL. Prevalence and Outcomes of Blood Transfusion Across Procedures and Clinical Conditions Warranting Inpatient Care: An Analysis of the 2004 Healthcare Cost and Utilization Project Nationwide Inpatient Sample Database. American Journal of Medical Quality. In Press.
Parker D & Walker B (2009, July 20). Capturing the Value of Traditional In Vitro Diagnostic Tests. Clinica Diagnostics. 47, 1-5.
Slawsky K (2009, August 17). Methods of Value Demonstration in IVD Technology. Clinica Diagnostics. 49, 1-5.
Slawsky K (2009, August 3). Changing Evidentiary Standards: Growth of the IVD Market and Heightened Evidence Requirements. Clinica Diagnostics. 48, 1-5.
Szende A, Schaefer C, Goss TF, Heptinstall K, Knight R, Lubbert M, Deschler B, Fenaux P, Mufti GJ, Killick S, & List AF (2009, September 8). Valuation of Transfusion-free Living in MDS: Results of Health Utility Interviews with Patients. Health and Quality of Life Outcome 2009. 7(81), doi:10.1186/1477-7525-7-81.
Brandenburg NA, Goss TF, Knight T, Xu X, & Knight RD (2008, December 7). Evaluation of the Relationship Between Venous Thromboembolism Risk Factors and the Use of Antithrombotic Prophylaxis in Multiple Myeloma Patients Treated with Thalidomide and Dexamethasone Combination Regimens. American Society of Hematology (ASH) Annual Meeting Abstracts 2008, 112: 2369.
Chan S quoted in Steinke S (2008, December). Experimental Cost Controls: Plans Moving Doctor-Administered Drugs from Medical to Pharmacy Benefit. CMS Beat as published in The RPM Report. 3(17).
Cruess A, Zlateva G, Xu X, Soubrane G, Pauleikhoff D, Lotery A, Monès J, Buggage R, Schaefer C, Knight T, & Goss T (2008). Economic Burden of Neovascular Age-Related Macular Degeneration: A Multi-country Study. Pharmacoeconomics. 26(1), 57-73.
James AH, Patel ST, Watson W, Zaidi QR, Mangione A, & Goss TF (2008). An Assessment of Medical Resource Utilization and Hospitalization Cost Associated with a Diagnosis of Anemia in Women with Obstetrical Bleeding in the United States. Journal of Women’s Health. 17, 1279-1284.
Lerner J, Patel ST, & Goss TF (2008, May 5). A Prevalence-Based Economic Analysis of the Growth in Cancer Treatment Spending in the United States. Presented at ISPOR Thirteenth Annual Meeting. Value in Health 2008, 11(3), A82.
Morrison J, Patel ST, Watson W, Zaidi QR, Mangione A, & Goss TF (2008). Assessment of the Prevalence and Impact of Anemia on Women Hospitalized for Gynecologic Conditions Associated With Heavy Uterine Bleeding. Journal of Reproductive Medicine. 53, 323–330.
Patel ST, Anastassopoulos K, Lerner J, Ryan K, Dodd SL, Goss TF, & Morton J (2008, November 8-11). Clinical and Economic Outcomes Associated with Blood Transfusion during Inpatient Hospitalization: An Analysis of the 2004 Health Care Cost and Utilization Project Nationwide Inpatient Sample Database. Presented at ISPOR Eleventh Annual European Congress. Value in Health 2008.
Schaefer C, Lerner J, Santillo C, & Goss T (2008, May 5). The Role of the Academy of Managed Care Pharmacy (AMCP) Format in Managed Care Formulary and Coverage Decisionmaking. Presented at ISPOR Thirteenth Annual Meeting. Value in Health 2008, 11(3) A48.
Xu X, Barron RL, Mautner B, & Goss TF (2008, November 8-11). Association between Respondent- and Practice-related Characteristics and Oncology Staff-reported Burden on Mucositis Management for Head and Neck Cancer (HNC) Patients. Presented at ISPOR Eleventh Annual European Congress. Value in Health 2008.
Xu, X, Barron RL, Mautner B, Ryan K, & Goss TF (2008, September 21-25). Burden of Mucositis Management on Radiation Oncology Facility Staff Treating Head and Neck Cancer Patients. Presented at The American Society for Therapeutic Radiology and Oncology (ASTRO) 50th Annual Meeting, Boston, MA.
See Archives